Knowtex From Scribe to AI Lab
Caroline Zhang, CEO of Knowtex, on going from AI medical scribe to AI lab
This turns the scribe from a labor saving tool into a data engine for clinical discovery. Knowtex is saying the valuable output is not just the note, but the full chain of what was in the chart, what the patient said, and what the doctor decided. That creates a live stream of expert checked examples that can be mined for treatment patterns, trial matching, and disease specific insights for health systems, researchers, and drug companies.1 2 3
- In practice, this starts with workflow capture. Knowtex pulls chart context before the visit, records the conversation during the visit, then generates notes, codes, orders, care coordination steps, and trial routing after the visit. The research layer sits on top of that same workflow, not beside it.1 2
- The strategic bet is that ambient documentation creates a new kind of medical dataset. Instead of claims data or old chart snapshots, the company captures symptoms, reasoning, and decisions in real time, then has the clinician verify the output. That is what makes the data more useful for model tuning and pattern matching.1
- This is also how Knowtex tries to escape scribe commoditization. In AI scribes, note generation is getting crowded, with EHR vendors and rivals like Abridge, Ambience, and Freed expanding into coding, orders, and broader workflow tools. Owning the clinical reasoning record gives Knowtex a path into research and pharma budgets, not just documentation software spend.1 2 3
The next phase of the category is a split between simple note taking features and deeper clinical systems that learn from every encounter. If Knowtex can keep turning visits into usable, specialty specific evidence, the winner will look less like a transcription app and more like a clinical intelligence layer that sits between the EHR, the doctor, and the research pipeline.1 2 3